A 20-year-old womanwith IgA nephropathy was admitted to Jikei University Hospital for the treatment of rapid deterioration of renal function after receiving 131I-therapy against hyperthyroidism on October 23, 1999, and hemodialysis was started. On admission, she was diagnosed as having Evans' syndrome in addition to known Graves9 disease. Renal biopsy revealed end-stage renal damage, then, hemodialysis was maintained. Treatment for Evans9 syndromewas also started and her general condition gradually improved. The present case implied that "Graves9 disease99 and "Evans9 syndrome99 could represent some of the manifestations of an underlying immunological disorder in the patient.

No abstract